Search Results - "Calverley, P"

Adherence to inhaled therapy, mortality and hospital admission in COPD by Vestbo, J, Anderson, J A, Calverley, P M A, Celli, B, Ferguson, G T, Jenkins, C, Knobil, K, Willits, L R, Yates, J C, Jones, P W

“…Little is known about adherence to inhaled medication in chronic obstructive pulmonary disease (COPD) and the impact on mortality and morbidity. Data on drug…”
Get more information

Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results by Crim, C, Calverley, P. M. A, Anderson, J. A, Celli, B, Ferguson, G. T, Jenkins, C, Jones, P. W, Willits, L. R, Yates, J. C, Vestbo, J

“…Inhaled corticosteroids (ICS) are important in reducing exacerbation frequency associated with chronic obstructive pulmonary disease (COPD). However, little is…”
Get full text

Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease by CALVERLEY, P. M, BOONSAWAT, W, CSEKE, Z, ZHONG, N, PETERSON, S, OLSSON, H

“…Lung function in chronic obstructive pulmonary disease (COPD) can be improved acutely by oral corticosteroids and bronchodilators. Whether clinical improvement…”
Get full text

Measurements of the ultraviolet background at 4.6 < z < 6.4 using the quasar proximity effect by Calverley, Alexander P., Becker, George D., Haehnelt, Martin G., Bolton, James S.

“…We present measurements of the ionizing ultraviolet background (UVB) at z∼ 5-6 using the quasar proximity effect. The 15 quasars in our sample cover the range…”
Get full text

Seasonality and determinants of moderate and severe COPD exacerbations in the TORCH study by JENKINS, C. R, CELL, B, ANDERSON, J. A, FERGUSON, G. T, JONES, P. W, VESTBO, J, YATES, J. C, CALVERLE, P. M. A

“…We investigated the impact of season relative to other determinants of chronic obstructive pulmonary disease (COPD) exacerbation frequency in a long-term…”
Get full text

Chronic obstructive pulmonary disease by Calverley, PMA, Walker, Paul

“…Chronic obstructive pulmonary disease (COPD) is a major cause of death and disability worldwide. Recognition that the burden of this disorder will continue to…”
Get full text

Cardiovascular and metabolic effects of CPAP in obese males with OSA by Coughlin, S. R, Mawdsley, L, Mugarza, J. A, Wilding, J. P. H, Calverley, P. M. A

“…Obstructive sleep apnoea is associated with increased blood pressure and other features of the metabolic syndrome. The aim of the present study was to…”
Get full text

Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial by Burge, P S, Calverley, P M A, Jones, P W, Spencer, S, Anderson, J A, Maslen, T K

“…AbstractObjectives: To determine the effect of long term inhaled corticosteroids on lung function, exacerbations, and health status in patients with moderate…”
Get full text

Flow limitation and dynamic hyperinflation: key concepts in modern respiratory physiology by Calverley, P. M. A, Koulouris, N. G

“…Fashions in ideas, like clothes, come and go. From approximately 1950-1980, physiological research was seen as the key discipline in understanding lung disease…”
Get full text

Lower limb activity and its determinants in COPD by Walker, P P, Burnett, A, Flavahan, P W, Calverley, P M A

“…Patients with chronic obstructive pulmonary disease (COPD) walk less than healthy older people and their self-reported activity predicts exacerbation risk. The…”
Get more information

The effect of neoadjuvant chemotherapy on physical fitness and survival in patients undergoing oesophagogastric cancer surgery by Jack, S, West, M.A, Raw, D, Marwood, S, Ambler, G, Cope, T.M, Shrotri, M, Sturgess, R.P, Calverley, P.M.A, Ottensmeier, C.H, Grocott, M.P.W

“…Abstract Background Neoadjuvant chemotherapy (NAC) followed by surgery for resectable oesophageal or gastric cancer improves outcome when compared with surgery…”
Get full text

Overnight variation in tidal expiratory flow limitation in COPD patients and its correction: an observational study by McKenzie, J, Nisha, P, Cannon-Bailey, S, Cain, C, Kissel, M, Stachel, J, Proscyk, C, Romano, R, Hardy, B, Calverley, P M A

“…Tidal expiratory flow limitation (EFL ) is common among COPD patients. Whether EFL changes during sleep and can be abolished during home ventilation is not…”
Get full text

Hyperglycaemia as a predictor of outcome during non-invasive ventilation in decompensated COPD by Chakrabarti, B, Angus, R M, Agarwal, S, Lane, S, Calverley, P M A

“…Hyperglycaemia predicts a poor outcome in Intensive Care Unit (ICU) patients. Whether this is true for respiratory failure necessitating non-invasive…”
Get more information

Beclomethasone/formoterol in the management of COPD: A randomised controlled trial by Calverley, P.M.A, Kuna, P, Monsó, E, Costantini, M, Petruzzelli, S, Sergio, F, Varoli, G, Papi, A, Brusasco, V

“…Summary Objectives To evaluate the effect of beclomethasone/formoterol versus budesonide/formoterol (non-inferiority) and versus formoterol (superiority) in…”
Get full text

Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease by Sin, D D, Wu, L, Anderson, J A, Anthonisen, N R, Buist, A S, Burge, P S, Calverley, P M, Connett, J E, Lindmark, B, Pauwels, R A, Postma, D S, Soriano, J B, Szafranski, W, Vestbo, J

“…Background: Clinical studies suggest that inhaled corticosteroids reduce exacerbations and improve health status in chronic obstructive pulmonary disease…”
Get full text

Effect of bronchodilation on expiratory flow limitation and resting lung mechanics in COPD by Dellaca, R. L, Pompilio, P. P, Walker, P. P, Duffy, N, Pedotti, A, Calverley, P. M. A

“…Bronchodilator drugs produce variable improvements in forced expiratory volume in 1 s (FEV(1)), but larger changes in end-expiratory lung volume (EELV) in…”
Get full text

Bronchodilator reversibility testing in chronic obstructive pulmonary disease by Calverley, P M A, Burge, P S, Spencer, S, Anderson, J A, Jones, P W

“…Background: A limited or absent bronchodilator response is used to classify chronic obstructive pulmonary disease (COPD) and can determine the treatment…”
Get full text

Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial by Davies, L, Angus, RM, Calverley, PMA

“…The role of oral corticosteroids in treating patients with exacerbations of chronic obstructive pulmonary disease (COPD) remains contentious. We assessed in a…”
Get full text

Statistical analysis of exacerbation rates in COPD: TRISTAN and ISOLDE revisited by Keene, O. N, Calverley, P. M. A, Jones, P. W, Vestbo, J, Anderson, J. A

“…Various statistical methods have been used to measure the impact of treatment on chronic obstructive pulmonary disease (COPD) exacerbations. Poisson regression…”
Get full text

Impact of preventing exacerbations on deterioration of health status in COPD by Spencer, S, Calverley, P.M.A, Burge, P.S, Jones, P.W

“…Exacerbations of chronic obstuctive pulmonary disease (COPD) are associated with worse health status. The Inhaled Steroids in Obstructive Lung Disease in…”
Get full text